Cited by 447Coronary Interventions and DiagnosticsCardiac and Coronary Surgery TechniquesCardiac Imaging and Diagnostics

The Final 10-Year Follow-Up Results From the BARI Randomized Trial

Open access
The BARI Investigators·2007·Journal of the American College of Cardiology

Abstract

Objectives We sought to compare 10-year clinical outcomes in the BARI (Bypass Angioplasty Revascularization Investigation) trial patients who were randomly assigned to percutaneous transluminal coronary balloon angioplasty (PTCA) versus coronary artery bypass grafting (CABG).Background Angioplasty and bypass surgery have been compared in numerous studies, but long-term clinical outcomes are limited.Methods Symptomatic patients with multivessel coronary artery disease (n = 1,829) were randomly assigned to initial treatment with PTCA or CABG and followed up for an average of 10.4 years. Analyses were conducted on an intention-to-treat basis.Results The 10-year survival was 71.0% for PTCA and 73.5% for CABG (p = 0.18). At 10 years, the PTCA group had substantially higher subsequent revascularization rates than the CABG group (76.8% vs. 20.3%, p < 0.001), but angina rates for the 2 groups were similar. In the subgroup of patients with no treated diabetes, survival rates were nearly identical by randomization (PTCA 77.0% vs. CABG 77.3%, p = 0.59). In the subgroup with treated diabetes, the CABG assigned group had higher survival than the PTCA assigned group (PTCA 45.5% vs. CABG 57.8%, p = 0.025).Conclusions There was no significant long-term disadvantage regarding mortality or myocardial infarction associated with an initial strategy of PTCA compared with CABG. Among patients with treated diabetes, CABG conferred long-term survival benefit, whereas the 2 initial strategies were equivalent regarding survival for patients without diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2006.11.048

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Alderman EL, Stadius M. The angiographic definitions of the Bypass Angioplasty Revascularization Investigation. Coron Artery Dis 1992; 3:1189 -207.
  2. Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. J Am Coll Cardiol 2005;46:575-81.

Cited by

Sorted by citations

Authors
The BARI Investigators
Corresponding author
The BARI Investigators
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2007-04
Volume
49
Issue
15
Pages
1600-1606
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2341375528
Cited by
447
References
14
Citations by year
2025: 8 · 2024: 4 · 2023: 12 · 2022: 11 · 2021: 9 · 2020: 18 · 2019: 20 · 2018: 17 · 2017: 26 · 2016: 28 · 2015: 36 · 2014: 38 · 2013: 39 · 2012: 36
FWCI
33.87
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5u01hl038532-11, 5u01hl038504-10, 5u01hl038556-10, 5u01hl038512-10, 5u01hl038642-11, 2u01hl038514-09, 5u01hl038509-10, 5u01hl038518-11, 5u01hl038529-11, 2u01hl038524-09, 2u01hl038493-09)
  • National Heart, Lung, and Blood Institute (HL 38610, HL-38509, HL42145, HL-38529, HL38524-5, HL38514-6, HL38556, HL-38493, HL-38532, HL38642, HL-38504, HL-38518, HL 38512, U01HL038610)
Topics
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, multivessel coronary artery disease, long-term survival, revascularization, myocardial infarction, diabetes mellitus, coronary revascularization strategy
MeSH terms
Aged, Aged, 80 and over, Coronary Artery Bypass, Coronary Disease, Evaluation Studies as Topic, Female, Follow-Up Studies, Humans, Male, Middle Aged, Probability, Severity of Illness Index, Time Factors, Vascular Patency, Angioplasty, Balloon, Coronary, Survival Rate, Proportional Hazards Models, Treatment Outcome, Coronary Angiography, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review